{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T06:30:38Z","timestamp":1764657038889,"version":"3.46.0"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Performance-enhancing drug (PED) use\u2014particularly anabolic\u2013androgenic steroids (AAS)\u2014has expanded from competitive sport into mainstream fitness settings. Although PED use is associated with emotional, cognitive, and social difficulties, less is known about how duration of use or psychosocial factors shape these outcomes. Understanding these dynamics is essential for identifying individuals at greater risk for psychological impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 285 adult gym-goers (87 long-term users, 95 short-term users, 103 non-users) completed validated measures of depression (BDI-II), anxiety (BAI), muscle dysmorphia (MDDI), self-efficacy (GSE), social support (MSPSS), and social functioning (SASS), along with the Stroop test assessing executive function. Group comparisons, multiple regressions, and PROCESS-based mediation and moderation analyses were conducted, controlling for demographic covariates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Long-term PED users reported significantly higher depression, anxiety, and muscle dysmorphia than short-term users and non-users, and showed poorer Stroop interference performance. Mediation analysis revealed that depression and anxiety partially explained the link between PED use and poorer social functioning. Moderation results indicated that stronger self-efficacy and higher perceived social support buffered depressive and anxious symptoms among users.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Chronic PED use is associated with heightened emotional distress and reduced executive functioning, which in turn contribute to impaired social functioning. However, psychosocial resources such as self-efficacy and social support may mitigate these adverse effects. These findings underscore the need for routine psychological assessment and the development of supportive, prevention-oriented interventions for individuals engaged in PED use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2025.1710046","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T06:26:57Z","timestamp":1764656817000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychological correlates of performance-enhancing drug use: Emotional, cognitive, and social functioning in long-term and short-term users"],"prefix":"10.3389","volume":"16","author":[{"given":"Metin","family":"\u00c7\u0131naro\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eda","family":"Y\u0131lmazer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/su14052868","article-title":"Characteristics of gym-goers\u2019 performance-enhancing substance use","volume":"14","author":"Tavares","year":"2022","journal-title":"Sustainability"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/hsc.12326","article-title":"The injecting use of image and performance-enhancing drugs (IPED) in the general population: A systematic review","volume":"25","author":"Brennan","year":"2017","journal-title":"Health Soc Care Community"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-06751-3","article-title":"Harm reduction in male patients actively using anabolic androgenic steroids (AAS) and performance-enhancing drugs (PEDs): A review","volume":"36","author":"Bonnecaze","year":"2021","journal-title":"J Gen Internal Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/17482631.2021.1927490","article-title":"Men\u2019s experiences of using anabolic androgenic steroids","volume":"16","author":"B\u00f6rjesson","year":"2021","journal-title":"Int J Qual Stud Health Well-being"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104636","article-title":"Examining the association between trenbolone, psychological distress, and aggression among males who use anabolic-androgenic steroids","volume":"134","author":"Piatkowski","year":"2024","journal-title":"Int J Drug Policy"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fspor.2024.1404551","article-title":"Anabolic steroid consumption among gym-goers in Amman: knowledge, attitudes, and behaviors","volume":"6","author":"AlKasasbeh","year":"2024","journal-title":"Front Sports Active Living"},{"key":"B7","volume-title":"Doping, performance-enhancing drugs, and hormones in","author":"Hackney","year":"2017"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1080\/01639625.2023.2211209","article-title":"A triad of physical masculinities: Examining multiple \u2018hegemonic\u2019 bodybuilding identities in anabolic-androgenic steroid (AAS) online discussion groups","volume":"44","author":"Adams","year":"2023","journal-title":"Deviant Behav"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2017.1359708","article-title":"Body image and eating disorders are common","volume":"36","author":"Piacentino","year":"2017","journal-title":"J Addictive Dis"},{"key":"B10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-3-319-90817-5_5","article-title":"Body dysmorphic disorder and muscle dysmorphia","volume-title":"Body image, eating, and weight: A guide to assessment, treatment, and prevention","author":"Cuzzolaro","year":"2018"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/1747-597X-3-7","article-title":"Psychological drivers in doping: The life-cycle model of performance enhancement","volume":"3","author":"Petr\u00f3czi","year":"2008","journal-title":"Subst Abuse Treatment Prevention Policy"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/1403494820973096","article-title":"Prevalence, mental health and substance use of anabolic steroid users: A population-based study on young individuals","volume":"49","author":"Gestsdottir","year":"2021","journal-title":"Scandinavian J Public Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2008.05.004","article-title":"Long-term psychiatric and medical consequences of anabolic\u2013androgenic steroid abuse: A looming public health concern","volume":"98","author":"Kanayama","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"B14","unstructured":"Skauen\n              JE\n            \n          \n          Norway\n          University of Bergen\n          Lifetime prevalence, correlates, and sequelae of anabolic-androgenic steroid dependence: A meta-analysis, meta-regression analysis, and meta-synthesis\n          \n          2023"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.peh.2025.100337","article-title":"Cognitive functioning and psychiatric symptoms in users of anabolic steroids","volume":"39","author":"Scarth","year":"2025","journal-title":"Perform Enhancement Health"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.11.008","article-title":"Cognitive deficits in long-term anabolic-androgenic steroid users","volume":"130","author":"Kanayama","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107874","article-title":"Anabolic androgenic steroid dependence is associated with executive dysfunction","volume":"208","author":"Hauger","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2025.1553997","article-title":"Case report: Physiological and psychological underpinnings of muscle dysmorphia using EEG, GSR, and eye-tracking","volume":"16","author":"\u00c7\u0131naro\u011flu","year":"2025","journal-title":"Front Psychol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1192\/bjp.2025.73","article-title":"Anabolic-androgenic steroid use disorder: Case for recognition as a substance use disorder with specific diagnostic criteria","author":"Scarth","year":"2025","journal-title":"Br J Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e2815","DOI":"10.1002\/hup.2815","article-title":"Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings","volume":"37","author":"Piacentino","year":"2022","journal-title":"Hum Psychopharmacology: Clin Exp"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.730167","article-title":"Effects of appearance- and performance-enhancing drugs on personality traits","volume":"12","author":"Zaami","year":"2021","journal-title":"Front Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/add.16643","article-title":"What is the prevalence of anabolic-androgenic steroid use among women? A systematic review","volume":"119","author":"Piatkowski","year":"2024","journal-title":"Addiction"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/DBP.0b013e3181b33659","article-title":"Sports participation as a protective factor against depression and suicidal ideation in adolescents as mediated by self-esteem and social support","volume":"30","author":"Babiss","year":"2009","journal-title":"J Dev Behav Pediatr"},{"key":"B24","article-title":"General self-efficacy scale--revised--English version","author":"Jerusalem","year":"1995"},{"key":"B25","article-title":"The adaptation study of General Self-Efficacy (GSE) Scale to Turkish","volume":"11","author":"Aypay","year":"2010","journal-title":"Inonu Univ J Faculty Educ"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/da.20371","article-title":"Beck Depression Inventory II: Evaluation of the psychometric properties and cut-off points in a Turkish adult population","volume":"25","author":"Kapc\u0131","year":"2008","journal-title":"Depression Anxiety"},{"key":"B27","article-title":"Turkish version of the Beck Anxiety Inventory: Psychometric properties","volume":"12","author":"Ulusoy","year":"1998","journal-title":"J Cogn Psychother"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2174\/1573401314666181012113904","article-title":"Validity and reliability study of Turkish version of \u201cmuscle dysmorphic disorder inventory\u201d and \u201cbodybuilder image grid\u201d scales","volume":"15","author":"Devrim","year":"2019","journal-title":"Curr Nutr Food Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2224\/sbp.2008.36.10.1303","article-title":"Validity and reliability of the multidimensional scale of perceived social support-revised, with a Turkish sample","volume":"36","author":"Ba\u015fol","year":"2008","journal-title":"Soc Behav Personality: Int J"},{"key":"B30","first-page":"3","article-title":"Reliability and validity of the Turkish version of the Social Adaptation Self-Evaluation Scale (SASS)","volume":"19","author":"Akkaya","year":"2008","journal-title":"Turkish J Psychiatry"},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195134759.003.0002","article-title":"Neuropsychological assessment","volume-title":"Principles of behavioral and cognitive neurology","author":"Weintraub","year":"2000"},{"key":"B32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5080\/u23549","article-title":"Validity, reliability and normative data of the Stroop Test \u00c7apa version","volume":"31","author":"Sava\u015f","year":"2020","journal-title":"Turkish J Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1017\/S0033291724003271","article-title":"Long-term physical health conditions and youth anxiety and depression: Is there a causal link","volume":"55","author":"Shakeshaft","year":"2025","journal-title":"psychol Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X13666141210222725","article-title":"Anabolic-androgenic steroid use and psychopathology in athletes: A systematic review","volume":"13","author":"Piacentino","year":"2015","journal-title":"Curr Neuropharmacology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2337717","article-title":"Anabolic-androgenic steroids are linked to depression and anxiety in male bodybuilders: The hidden psychogenic side of anabolic androgenic steroids","volume":"56","author":"Karagun","year":"2024","journal-title":"Ann Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12850","article-title":"Health consequences of androgenic anabolic steroid use","volume":"285","author":"Horwitz","year":"2019","journal-title":"J Internal Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare9010097","article-title":"Adverse effects of anabolic-androgenic steroids: A literature review","volume":"9","author":"Albano","year":"2021","journal-title":"Healthcare (Basel)"},{"key":"B38","unstructured":"Annakin\n              J\n            \n          \n          United Kingdom\n          Birmingham City University\n          Understanding continuous and problematic patterns of anabolic androgenic steroid (AAS) use amongst UK males\n          \n          2021"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.2012.01123","article-title":"Psychological and physical impact of anabolic-androgenic steroid dependence","volume":"32","author":"Ip","year":"2012","journal-title":"Pharmacotherapy"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-019-05239-7","article-title":"Anabolic androgenic steroid dependence is associated with impaired emotion recognition","volume":"236","author":"Hauger","year":"2019","journal-title":"Psychopharmacology"},{"key":"B41","first-page":"1","article-title":"Everyday memory deficits associated with anabolic-androgenic steroid use in regular gymnasium users","volume":"9","author":"Heffernan","year":"2015","journal-title":"Open Psychiatry J"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1037\/neu0000537","article-title":"Cognitive performance and structural brain correlates in long-term anabolic-androgenic steroid exposed and nonexposed weightlifters","volume":"33","author":"Bj\u00f8rnebekk","year":"2019","journal-title":"Neuropsychology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55070396","article-title":"Neuropsychiatric and behavioral involvement in AAS abusers: A literature review","volume":"55","author":"Bertozzi","year":"2019","journal-title":"Med (Kaunas)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.drugalcdep.2015.04.023","article-title":"Brain and cognition abnormalities in long-term anabolic-androgenic steroid users","volume":"152","author":"Kaufman","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"B45","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.biopsych.2016.06.017","article-title":"Structural brain imaging of long-term anabolic-androgenic steroid users and nonusing weightlifters","volume":"82","author":"Bj\u00f8rnebekk","year":"2017","journal-title":"Biol Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2016.11.014","article-title":"Brain connectivity aberrations in anabolic-androgenic steroid users","volume":"13","author":"Westlye","year":"2017","journal-title":"NeuroImage: Clin"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pscychresns.2016.12.003","article-title":"White matter abnormalities in long-term anabolic-androgenic steroid users: A pilot study","volume":"260","author":"Seitz","year":"2017","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/11.3.322","article-title":"Adolescent use of anabolic-androgenic steroids and relations to self-reports of social, personality and health aspects","volume":"11","author":"Kindlundh","year":"2001","journal-title":"Eur J Public Health"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1159\/000433580","article-title":"Anti-social behaviors associated with anabolic-androgenic steroid use among male adolescents","volume":"21","author":"Hallgren","year":"2015","journal-title":"Eur Addict Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12905-025-03711-5","article-title":"Psychological traits associated with anabolic androgenic steroid use and dependence: An exploratory cross-sectional study among female athletes","volume":"25","author":"Scarth","year":"2025","journal-title":"BMC Women\u2019s Health"},{"key":"B51","doi-asserted-by":"publisher","first-page":"49582","DOI":"10.4088\/PCC.23r03532","article-title":"Association of body dysmorphic\u2013induced anabolic-androgenic steroid use with mental health outcomes: A systematic review","volume":"25","author":"Gawash","year":"2023","journal-title":"Primary Care Companion CNS Disord"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1177\/00914509241256002","article-title":"Performance and image enhancing drug use among Australian women: The role of interpersonal relationships in facilitating use","volume":"51","author":"Piatkowski","year":"2024","journal-title":"Contemp Drug Problems"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2022.101691","article-title":"Common symptoms associated with usage and cessation of anabolic androgenic steroids in men","volume":"36","author":"Sharma","year":"2022","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B54","article-title":"Measures of aggression and mood changes in male weightlifters with and without androgenic anabolic steroid use","volume":"48","author":"Yates","year":"2003","journal-title":"J Forensic Sci"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950050035004","article-title":"Psychiatric and medical effects of anabolic-androgenic steroid use: A controlled study of 160 athletes","volume":"51","author":"Pope","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"B56","unstructured":"Imran\n              FH\n            \n          \n          Ireland\n          University College Dublin, School of Medicine\n          From zero to hero, with the man in the mirror: Engagement of performance-enhancing drugs (PEDs) in young males\n          \n          2022"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05603-y","article-title":"Theory of mind in users of anabolic androgenic steroids","volume":"237","author":"Vaskinn","year":"2020","journal-title":"Psychopharmacology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000505978","article-title":"Anabolic-androgenic steroid use and body image in men: A growing concern for clinicians","volume":"89","author":"Kanayama","year":"2020","journal-title":"Psychother Psychosomatics"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/eat.23708","article-title":"Appearance and performance-enhancing drugs and supplements, eating disorders, and muscle dysmorphia among gender minority people","volume":"55","author":"Nagata","year":"2022","journal-title":"Int J Eating Disord"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.12968\/bjon.2023.0176","article-title":"Muscle dysmorphia: An under-recognised aspect of body dissatisfaction in men","volume":"33","author":"Watters","year":"2024","journal-title":"Br J Nurs"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1037\/men0000487","article-title":"Relationships between social media, body image, physical activity, and anabolic-androgenic steroid use in men: A systematic review","author":"Beos","year":"2024","journal-title":"Psychol Men Masculinities"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291720005206","article-title":"Prevalence of muscle dysmorphia in adolescents: Findings from the EveryBODY study","volume":"52","author":"Mitchison","year":"2022","journal-title":"psychol Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2025.1645274","article-title":"Sports motivation: a narrative review of psychological approaches to enhance athletic performance","volume":"16","author":"Alkasasbeh","year":"2025","journal-title":"Front Psychol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1177\/1359105319887796","article-title":"Body image dissatisfaction in adolescents: Comparison with physical activity, teasing and social support","volume":"26","author":"Gonzaga","year":"2021","journal-title":"J Health Psychol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1080\/09687637.2020.1865273","article-title":"Preventing, producing, or reducing harm? Fitness doping risk and enabling environments","author":"Henning","year":"2022","journal-title":"Drugs: Education Prev Policy"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1710046\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T06:27:02Z","timestamp":1764656822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1710046\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":65,"alternative-id":["10.3389\/fpsyt.2025.1710046"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1710046","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"article-number":"1710046"}}